The longitudinal change pattern of cognitive subtypes in medication-free patients with major depressive disorder: a cluster analysis

Psychiatry Res. 2023 Sep:327:115413. doi: 10.1016/j.psychres.2023.115413. Epub 2023 Aug 12.

Abstract

This study aimed to investigate whether there are different cognitive subtypes in patients with major depressive disorder (MDD) and the change pattern of cognitive clusters across the course of MDD. A battery of comprehensive cognitive tests was used to assess the executive function, processing speed, attention, and memory of 153 medication-free patients and 142 healthy controls (HCs). After 6 months of treatment with antidepressants, 87 patients completed cognitive tests again. K-means cluster analysis was performed to determine the cognitive subtypes. A preserved cognition cluster and an impaired cognition cluster were identified in the acute episode phase and the 6-month follow-up phase. 80.5% of the patients remained in their original subgroup after 6 months of treatment. The impaired cognition cluster during the 6-month follow-up period could be predicted by impaired cognition during the episode phase, disease state (remission or non-remission), current illness duration, and education level. This study supporting the heterogeneity of cognitive performance across the course of disease in patients with MDD using cluster analysis. It was found that cognitive impairment during depressive episodes was predictive of poorer cognitive performance even after treatment with antidepressants. Therefore, interventions targeting cognitive function from the early stages of MDD is essential.

Keywords: Major depressive disorder; cluster analysis; cognitive subtype; heterogeneity; longitudinal study.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antidepressive Agents / therapeutic use
  • Cluster Analysis
  • Cognition
  • Cognition Disorders* / etiology
  • Cognition Disorders* / psychology
  • Cognitive Dysfunction* / etiology
  • Depressive Disorder, Major* / complications
  • Depressive Disorder, Major* / drug therapy
  • Depressive Disorder, Major* / psychology
  • Humans
  • Neuropsychological Tests

Substances

  • Antidepressive Agents